The U.S. Department of Health and Human Services (HHS) have set a goal to eliminate Hepatitis C as a public health threat by 2030.
Elimination of Hepatitis C in the U.S. would result in the significant reduction of the incidence of the infection – to the point where cases of the infection are rare and sporadic – as a result of deliberate efforts, with ongoing efforts to maintain the zero prevalence.
In 2017, HHS released its 2017-2020 Viral Hepatitis Action Plan to set the course for elimination of Hepatitis B and C in the U.S.
Key Goals of the plan to work toward elimination are by 2020 to:
- Decrease the number of new HCV infections by at least 60%
- Increase the number of persons aware of their HCV infection to 66%
- Reduce the number of HCV-related deaths by 25%
- Reduce the number of new HCV infections in persons ages 20-39 by at least 60%
In 2016 and 2017. The National Academies of Sciences released a 2- part report on the Feasibility of Eliminating Hepatitis B and C in the U.S.
The availability of curative HCV drug treatments could make Hepatitis C elimination a reality, but only if those infected know their status, get treatment, and complete the course of therapy.
National Academies Viral Hepatitis Report – Part One